The introduction of new antiretroviral drugs with increased viral potency, as integrase inhibitors (INI), has changed the history of HIV. The higher potency has brought to light the necessity to reduce drug adverse effects, drug-drug interaction and costs. We conducted a multicentre observational study and we observed a group of people living with HIV (PLWH) who had switched to a two drugs regimen (2DR) for a year, comparing it with a group of PLWH who maintained the 3DR regimen, focusing on inflammation markers.
1605. Dual Therapy VS Triple Therapy in Experienced PLWH: a Multicentre One-Year Long Observational Study
Russotto, Ylenia;Saia, Antonino Gaspare;Rullo, Emmanuele Venanzi;Pellicanò, Giovanni Francesco;
2023-01-01
Abstract
The introduction of new antiretroviral drugs with increased viral potency, as integrase inhibitors (INI), has changed the history of HIV. The higher potency has brought to light the necessity to reduce drug adverse effects, drug-drug interaction and costs. We conducted a multicentre observational study and we observed a group of people living with HIV (PLWH) who had switched to a two drugs regimen (2DR) for a year, comparing it with a group of PLWH who maintained the 3DR regimen, focusing on inflammation markers.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
